Last10K.com

Sunesis Pharmaceuticals Inc (SNSS) SEC Filing 8-K Material Event for the period ending Tuesday, January 7, 2020

Sunesis Pharmaceuticals Inc

HISTORY TOOLS
CIK: 1061027 Ticker: SNSS

View differences made from one to another to evaluate Sunesis Pharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sunesis Pharmaceuticals Inc.

Continue

Assess how Sunesis Pharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sunesis Pharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: SNSS
CIK: 1061027
Form Type: 8-K Corporate News
Accession Number: 0001564590-20-000405
Submitted to the SEC: Tue Jan 07 2020 5:28:26 PM EST
Accepted by the SEC: Tue Jan 07 2020
Period: Tuesday, January 7, 2020
Industry: Pharmaceutical Preparations
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/snss/0001564590-20-000405.htm